{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:19:20Z","timestamp":1789712360422,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clae.2025.102568","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T23:48:15Z","timestamp":1763596095000},"page":"102568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical impact of varying the molecular weight of hyaluronic acid in artificial tears \u2013 A randomised controlled crossover trial"],"prefix":"10.1016","volume":"49","author":[{"given":"David A.","family":"Semp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarun","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-8927","authenticated-orcid":false,"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2025.102568_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/OPTH.S188314","article-title":"Dry eye disease ranking among common reasons for seeking eye care in a large US claims database","volume":"13","author":"Bradley","year":"2019","journal-title":"Clin Ophthalmol (Auckland Nz)"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2025.102568_b0030","article-title":"Annual direct economic burden and influencing factors of dry eye disease in Central China","author":"Luo","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"10.1016\/j.clae.2025.102568_b0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: a Systematic Literature Review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2025.102568_b0040","first-page":"107","article-title":"The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants","volume":"21","author":"Morthen","year":"2021","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.clae.2025.102568_b0045","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2025.102568_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009729.pub2","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","author":"Pucker","year":"2016","journal-title":"Cochrane Database of Systematic Reviews (2)"},{"issue":"5","key":"10.1016\/j.clae.2025.102568_b0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5301\/EJO.2011.6324","article-title":"Efficacy of 3 different artificial tears for the treatment of dry eye in frequent computer users and\/or contact lens users","volume":"21","author":"Calvao-Santos","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clae.2025.102568_b0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/OPTH.S74849","article-title":"Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial","volume":"9","author":"Simmons","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2025.102568_b0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jtos.2020.12.006","article-title":"Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: a six-month multicentre, double-masked randomised controlled trial","volume":"20","author":"Craig","year":"2021","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.clae.2025.102568_b0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.clae.2025.102568_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.optm.2010.08.003","article-title":"A review of hyaluronan and its ophthalmic applications","volume":"82","author":"Rah","year":"2011","journal-title":"Optometry-Journal of the American Optometric Association"},{"key":"10.1016\/j.clae.2025.102568_b0080","first-page":"3","article-title":"Hyaluronic acid and replacement of vitreous and aqueous humor","volume":"10","author":"Balazs","year":"1972","journal-title":"Mod Probl Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2025.102568_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00003226-198201020-00007","article-title":"The treatment of dry eyes with Na hyaluronate (Healon\u00ae)","volume":"1","author":"Polack","year":"1982","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.clae.2025.102568_b0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/jop.2017.0080","article-title":"Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model","volume":"34","author":"Carlson","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.clae.2025.102568_b0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/jop.2014.0164","article-title":"Effects of a Hyaluronic Acid\/Hydroxypropyl Guar Artificial Tear solution on Protection","volume":"31","author":"Rangarajan","year":"2015","journal-title":"Recovery, and Lubricity in Models of Corneal Epithelium, J Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.clae.2025.102568_b0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/diagnostics10080511","article-title":"Why chain length of hyaluronan in eye drops matters","volume":"10","author":"M\u00fcller-Lierheim","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.clae.2025.102568_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2015.00261","article-title":"The Content and size of Hyaluronan in Biological Fluids and Tissues","volume":"6","author":"Cowman","year":"2015","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.clae.2025.102568_b0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejcb.2006.05.009","article-title":"Hyaluronan fragments: an information-rich system","volume":"85","author":"Stern","year":"2006","journal-title":"Eur J Cell Biol"},{"issue":"10","key":"10.1016\/j.clae.2025.102568_b0115","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.3390\/ijms21103516","article-title":"The effects of high molecular weight hyaluronic acid eye drop application in environmental dry eye stress model mice","volume":"21","author":"Kojima","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4\u20135","key":"10.1016\/j.clae.2025.102568_b0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejps.2008.04.006","article-title":"In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride","volume":"34","author":"Pauloin","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.clae.2025.102568_b0125","first-page":"577","article-title":"High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells","volume":"15","author":"Pauloin","year":"2009","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/elps.201200342","article-title":"Hyaluronic acid\u2010dependent protection against alkali\u2010burned human corneal cells","volume":"34","author":"Wu","year":"2013","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.clae.2025.102568_b0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.11421","article-title":"Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents","volume":"50","author":"Gomis","year":"2004","journal-title":"Arthritis Rheumatism"},{"issue":"6","key":"10.1016\/j.clae.2025.102568_b0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00137947","article-title":"The viscosity of human tears","volume":"15","author":"Tiffany","year":"1991","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0927-7757(95)03097-W","article-title":"Non-Newtonian properties of hyaluronic acid aqueous solution","volume":"97","author":"Pis\u00e1r\u010dik","year":"1995","journal-title":"Colloids Surfaces a: Physicochemical Engineering Aspects"},{"issue":"5","key":"10.1016\/j.clae.2025.102568_b0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/j.jcrs.0000000000000508","article-title":"Role of rheology in tears and artificial tears","volume":"47","author":"Arshinoff","year":"2021","journal-title":"Journal of Cataract Refractive Surgery"},{"key":"10.1016\/j.clae.2025.102568_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OPTO.S350185","article-title":"Artificial Tears: a Systematic Review","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optom (auckl)"},{"issue":"6","key":"10.1016\/j.clae.2025.102568_b0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.8.6.2","article-title":"Physicochemical Properties of Hyaluronic Acid-based Lubricant Eye Drops","volume":"8","author":"Aragona","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.clae.2025.102568_b0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.05.031","article-title":"Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops","volume":"395","author":"Uccello-Barretta","year":"2010","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.clae.2025.102568_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.12.4.13","article-title":"Characterization of the Molecular Weight of Hyaluronan in Eye Products using a Novel Method of size Exclusion High-pressure Liquid Chromatography","volume":"12","author":"Nguyen","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.clae.2025.102568_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2017.10.005","article-title":"Randomized double-masked trial of eyelid cleansing treatments for blepharitis","volume":"16","author":"Sung","year":"2018","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.clae.2025.102568_b0180","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/OPX.0b013e318182476c","article-title":"Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment","volume":"85","author":"Johnson","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2025.102568_b0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jop.2016.0086","article-title":"A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye","volume":"33","author":"Park","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clae.2025.102568_b0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00417-005-0028-1","article-title":"Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye","volume":"244","author":"Johnson","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.clae.2025.102568_b0195","article-title":"Composition and Rheological Properties of Polysaccharide Extracted from Tamarind (Tamarindus indica L.) seed, Molecules (Basel","volume":"24","author":"Shao","year":"2019","journal-title":"Switzerland)"},{"issue":"3","key":"10.1016\/j.clae.2025.102568_b0200","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1021\/je9501402","article-title":"Viscosity and Density of Water + Sodium Chloride + Potassium Chloride Solutions at 298.15 K","volume":"41","author":"Zhang","year":"1996","journal-title":"J Chem Eng Data"},{"key":"10.1016\/j.clae.2025.102568_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2022.954771","article-title":"Topical ophthalmic administration: can a drug instilled onto the ocular surface exert an effect at the back of the eye?","volume":"2","author":"del Amo","year":"2022","journal-title":"Front Drug Delivery"},{"issue":"2","key":"10.1016\/j.clae.2025.102568_b0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2025.102568_b0215","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Investigative Ophthalmology & Vision Science"},{"issue":"12","key":"10.1016\/j.clae.2025.102568_b0220","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1167\/iovs.07-1407","article-title":"Rheology of tear film lipid layer spread in normal and aqueous tear-deficient dry eyes","volume":"49","author":"Yokoi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048425002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048425002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:06:00Z","timestamp":1768568760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048425002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1367048425002024"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2025.102568","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of varying the molecular weight of hyaluronic acid in artificial tears \u2013 A randomised controlled crossover trial","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2025.102568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102568"}}